Header cover image

Spanish (IBEX) Pharma Industry Analysis

UpdatedFeb 08, 2026
DataAggregated Company Financials
Companies5
  • 7D1.1%
  • 3M20.7%
  • 1Y35.8%
  • YTD6.0%

Over the last 7 days, the Pharma industry has risen 1.1%, driven by gains in Almirall and Laboratorios Farmaceuticos Rovi of 2.1% and 1.3%, respectively. This means that the industry has gained 36% over the past year. Looking forward, earnings are forecast to grow by 22% annually.

Industry Valuation and Performance

Has the Spanish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 09 Feb 2026€8.4b€2.8b€273.4m33.1x30.6x3x
Wed, 07 Jan 2026€8.1b€2.8b€273.4m37.9x29.7x2.9x
Fri, 05 Dec 2025€7.6b€2.8b€273.4m37x27.7x2.7x
Sun, 02 Nov 2025€7.4b€2.7b€265.3m30.4x28x2.8x
Tue, 30 Sep 2025€6.9b€2.7b€265.3m28.9x26x2.6x
Thu, 28 Aug 2025€6.9b€2.7b€265.3m29.8x25.9x2.6x
Sat, 26 Jul 2025€6.8b€2.7b€280.6m21.2x24.1x2.5x
Mon, 23 Jun 2025€6.8b€2.7b€284.5m21.6x23.8x2.5x
Wed, 21 May 2025€6.5b€2.7b€284.8m22.5x22.7x2.4x
Fri, 18 Apr 2025€6.0b€2.7b€267.7m19.6x22.2x2.2x
Sun, 16 Mar 2025€6.1b€2.7b€267.7m19.7x22.9x2.3x
Tue, 11 Feb 2025€6.1b€2.7b€226.1m17.1x27.2x2.3x
Thu, 09 Jan 2025€6.4b€2.7b€226.1m20x28.2x2.4x
Sat, 07 Dec 2024€6.3b€2.7b€226.1m19.7x28.1x2.4x
Mon, 04 Nov 2024€7.4b€2.5b€220.1m24.4x33.5x2.9x
Wed, 02 Oct 2024€7.0b€2.5b€219.5m24x31.7x2.7x
Fri, 30 Aug 2024€7.2b€2.5b€219.5m23.3x33x2.9x
Sun, 28 Jul 2024€7.9b€2.5b€206.3m25x38.5x3.2x
Tue, 25 Jun 2024€7.7b€2.5b€202.7m26x38x3.1x
Thu, 23 May 2024€8.0b€2.6b€193.1m24.6x41.4x3.1x
Sat, 20 Apr 2024€7.0b€2.6b€223.6m22x31.5x2.7x
Mon, 18 Mar 2024€6.8b€2.6b€223.6m21.1x30.5x2.6x
Wed, 14 Feb 2024€6.6b€2.6b€295.8m17.1x22.2x2.5x
Fri, 12 Jan 2024€6.2b€2.6b€296.4m16.3x21x2.4x
Sun, 10 Dec 2023€6.0b€2.6b€296.4m15.6x20.4x2.3x
Tue, 07 Nov 2023€5.5b€2.5b€276.0m13.7x20x2.2x
Thu, 05 Oct 2023€5.9b€2.5b€274.5m14.5x21.5x2.4x
Sat, 02 Sep 2023€6.0b€2.5b€274.5m15.1x21.9x2.4x
Mon, 31 Jul 2023€5.3b€2.5b€274.5m12.4x19.4x2.2x
Wed, 28 Jun 2023€4.8b€2.4b€284.3m11.3x16.8x2x
Fri, 26 May 2023€5.1b€2.4b€284.3m11.9x17.9x2.1x
Sun, 23 Apr 2023€5.0b€2.4b€301.6m17.9x16.7x2.1x
Tue, 21 Mar 2023€4.8b€2.4b€301.6m17.4x15.9x2x
Thu, 16 Feb 2023€5.1b€2.3b€275.8m30.5x18.6x2.2x
Price to Earnings Ratio

18.6x


Total Market Cap: €5.1bTotal Earnings: €275.8mTotal Revenue: €2.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Spanish Pharma Industry Price to Earnings3Y Average 25.7x202420252026
Current Industry PE
  • Investors are optimistic on the Spanish Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 30.6x which is higher than its 3-year average PE of 25.7x.
  • The 3-year average PS ratio of 2.5x is lower than the industry's current PS ratio of 3.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 5.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Spanish Healthcare industry?

ES Market0.42%
Healthcare0.66%
Pharma1.09%
Pharma1.09%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALM Almirall€12.880.5%
+€12.9m
41.5%PE65.8x